Wanfu Biotechnology | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
187,769.20
5,107.60
99,443.20
5,879.70
16,027.60
40,637.50
Depreciation, Depletion & Amortization
13,468.30
13,188.90
9,892.40
6,139.70
7,766.40
11,770.70
Other Funds
13,426.60
5,190.00
1,112.20
-
4,328.20
18,135
Funds from Operations
28,509.90
10,971.80
9,937.30
4,547.30
29,499.50
68,528.50
Changes in Working Capital
156,091.50
42,119.00
5,826.80
762.70
72,906.90
252,099.30
Net Operating Cash Flow
127,581.60
31,147.10
15,764.20
5,310.00
43,407.50
183,570.80
Capital Expenditures
71,746.90
13,377.80
13,662.60
8,289.20
7,671.20
Sale of Fixed Assets & Businesses
960.00
47,196.60
-
-
3,410.00
Purchase/Sale of Investments
-
-
50,000.00
20,000.00
-
Net Investing Cash Flow
70,786.90
33,818.70
61,280.20
52,710.80
10,452.20
Issuance/Reduction of Debt, Net
222,000.00
31,500.00
32,500.00
20,000.00
90,052.10
Net Financing Cash Flow
235,426.60
26,310.00
33,612.20
20,000.00
85,723.90
Net Change in Cash
178,631.90
38,655.90
110,656.60
38,020.80
30,427.80
Free Cash Flow
55,834.60
17,769.30
29,426.80
2,979.20
51,078.70
Deferred Taxes & Investment Tax Credit
167.40
-
-
-
120.80
2,014.70
Net Assets from Acquisitions
-
-
-
-
6,190.90
Other Sources
-
-
2,382.40
41,000.00
-
Exchange Rate Effect
-
-
-
-
1,436.50
About Wanfu Biotechnology
View Profile
